HEALTH

Vitamin D could be a piece of COVID-19's 'complex puzzle,' Israeli scientists say, after a new study finds a link between deficiency and severe illness

February 8th, 2022

Israeli scientists said they found "striking" differences in the chances of getting seriously ill from COVID-19 when they compared patients who had sufficient vitamin D levels prior to contracting the disease with those who didn't.

A study published on Thursday in the research journal PLOS One found that about half of people who were
vitamin D
deficient before getting COVID-19 developed severe illness, compared to less than 10% of people who had sufficient levels of the vitamin in their blood.

We know vitamin D is vital for bone health, but its role in protecting against severe COVID-19 is less well established.

The latest research was the first to examine vitamin D levels in people prior to them contracting COVID-19, the study authors said.

Dr. Amiel Dror, a study author and physician at the Galilee Medical Center, said of the findings, "We found it remarkable, and striking, to see the difference in the chances of becoming a severe patient when you are lacking in vitamin D compared to when you're not," The Times of Israel reported.

The findings come from 253 people admitted to Galilee Medical Center in Nahariya, Israel, between April 7, 2020, and February 4, 2021 — a period before the highly infectious Omicron variant emerged.

Buffalo Jeans - 15% Off First Order


Dror said the findings suggested that vitamin D helped bolster the immune system to deal with viruses that attack the respiratory system.

"This is equally relevant for Omicron as it was for previous variants," Dror said.

The research doesn't prove that vitamin D protects against COVID-19 and isn't a green light to avoid vaccines and take vitamins instead. Vaccines cut the risk of Omicron hospitalization, particularly after a booster, by up to 90%, the UK Health Security Agency said.

Most vitamin D comes from direct sunlight on the skin. It's also found in foods such as fatty fish, mushrooms, and egg yolks and in supplements.

Vitamin D levels of more than 20 nanograms per milliliter are considered sufficient for most people, said the Centers for Disease Control and Prevention — which is the benchmark used by the researchers from Bar-Ilan University and Galilee Medical Center.

Blackout Coffee

Research compiled before the emergence of COVID-19 and published in The Lancet found that vitamin D cut the risk of other respiratory infections, compared with dummy drugs.

But for COVID-19, early findings have been inconsistent: Some studies have found a link between low vitamin D levels and severe COVID-19, while others have concluded that the vitamin wasn't protective.

It wasn't clear — even from those studies with results showing a positive correlation between low vitamin D levels and severe COVID-19 — if depleted vitamin D came before or after people became sick, the Israeli researchers said.

Despite the new data from Israel, we still don't know if low vitamin D levels cause people with COVID-19 to develop serious disease.

Underlying conditions that reduce vitamin D can also make people more vulnerable to severe COVID-19, for example.

The Israeli researchers cautioned that vitamin D was "one piece of the complex puzzle" underlying severe COVID-19, in addition to comorbidities, genetic predisposition, dietary habits, and geographic factors.

"Our study warrants further studies investigating if and when vitamin D supplementation among vitamin D deficient individuals in the community impacts the outcome of an eventual COVID-19 episode," they said.

Curated By

Kaito Tanaka
Strategic Innovation Consultant | Technology Investment Analyst | Operations Research Director
Kaito Tanaka is a futurist journalist who approaches news through the lens of optimization and efficiency. Specializing in cutting-edge technologies like CRISPR, robotics, and supply chain innovations, he distills complex developments into their most actionable insights. Known for his clinical analysis style, Kaito cuts through traditional narratives to identify systemic inefficiencies and opportunities for progress. His commentary reflects a pragmatic worldview where sentiment yields to solutions, and every story is evaluated based on its potential to advance human capability. When he's not tracking breakthrough research, you'll find him optimizing his own workflow or planning his next travel adventure with mathematical precision.

Suggested Reading

From Killer to Common Cold: Herd Protection and the Transitional Phase of Covid-19

From Killer to Common Cold: Herd Protection and the Transitional Phase of Covid-19 by David M. Graham offers a comprehensive analysis of the SARS-CoV-2 pandemic’s evolution from a global crisis into a manageable endemic illness. Graham focuses primarily on the biological and sociological mechanisms ...

Overcoming the COVID-19 Darkness: How Two Doctors Successfully Treated 7000 Patients

No one needs to die! Overcoming the Darkness of COVID is about two doctors who used a treatment protocol early in the pandemic and early in treatment when the conventional wisdom issued was not to provide any treatment to patients and send them home until they got sick and then go to the hospital wh...

The Vitamin D Cure

Completely updated with the latest research, The Vitamin D Cure tells you all you need to know about this miraculous natural substance—today's best way to heal pain, prevent disease, and improve your mood. We now know that adding vitamin D to your daily regimen can net you unbelievable benefits, fro...

We use cookies to improve your experience on our website. By continuing to browse, you accept our Cookie Policy and Privacy Policy.